期刊文献+

肌电生物反馈技术治疗肠易激综合征的临床观察 被引量:12

Clinical observation of electromyographic biofeedback on irritable bowel syndrome
下载PDF
导出
摘要 目的:评价肌电生物反馈技术治疗肠易激综合征(IBS)的疗效。方法:将60例IBS患者随机分为试验组和对照组,两组均给予胃肠促动力药、肠道菌群调节药及植物神经调节药等常规药物治疗,试验组在此基础上给予为期4周的肌电生物反馈治疗。治疗前后分别对两组患者做抑郁自评量表(SDS)、焦虑自评量表(SAS)、胃肠道症状评定量表(GSRS)评分及内脏痛觉阈值测定。结果:治疗4周后,与对照组相比,试验组SDS、SAS和GSRS评分显著下降(P<0.05),内脏痛觉阈值明显升高(P<0.05)。结论:肌电生物反馈技术治疗IBS可明显改善患者心理障碍,降低患者内脏高敏感性,减轻患者胃肠道症状。 Objective: To evaluate the efficacy of electromyographic biofeedback on irritable bowel syndrome(IBS).Methods: A total of 60 patients with IBS were enrolled and randomized into trial group and control group.Similar dosage of gastrointestinal prokinetie agent,microecological modulator of intestinal flora and modulator of autonomic nerve were administered as baseline therapy in both groups.The patients in trial group were treated with electromyographic biofeedback therapy for 4 weeks.Self-rating depression scale(SDS),self-rating anxiety scale(SAS),gastrointestinal symptoms rating scale(GSRS) and the threshold of visceralgia were evaluated before and after treatment.Results: After treatment,compared with the control group,the scores of SDS,SAS and GSRS in trial group declined significantly(P〈0.05);the threshold of visceralgia increased significantly(P〈0.05).Conclusion: Electromyographic biofeedback therapy can improve the psychological disorder,visceralgia hypersensitivity and gastrointestinal symptoms on IBS.
出处 《东南大学学报(医学版)》 CAS 2011年第6期873-876,共4页 Journal of Southeast University(Medical Science Edition)
关键词 肠易激综合征 肌电生物反馈 心理障碍 内脏高敏感性 irritable bowel syndrome electromyographic biofeedback psychological disorder visceralgia hypersensitivity
  • 相关文献

参考文献4

二级参考文献37

  • 1蒋德胜.肠易激综合征患者的心理测验[J].中国行为医学杂志,1993,2(1):56-56. 被引量:2
  • 2Douglas A.Drossman,蒋晓玲(译),萧树东(校).罗马Ⅲ:新的标准[J].胃肠病学,2006,11(12):705-707. 被引量:513
  • 3Mertz H R.Irritable bowel syndrome[J].N Ensl J Med,2003,349(22):2136-2146. 被引量:1
  • 4Chang FY,Lu C L.Irritable bowel syndrome in the 21st century:perspectives from Asia or South-east Asia[J].J Gastroenterol Hepatol,2007,22(1):4-12. 被引量:1
  • 5Vandvik P O,Lydersen S,Farup P G.Prevalence.comorbidity and impact of irritable bowel syndrome in Norway[J].Soand J Gastroenterol,2006,41(4):650-656. 被引量:1
  • 6Schmulson M,Ortíz O,Santiago-Lomeli M,et al.Frequency of functional bowel disorders among healthy volunteers in Mexico City[J].Dig Dis,2006,24(3-4):342-347. 被引量:1
  • 7Levy R L,Jones K R,Whitehead W E,et al.Irritable bowel syndrome in twins:heredity and social learning both contribute to etiology[J].Gastroenterology,2001,121(4):799-804. 被引量:1
  • 8Hohmann G,Siffert W,Hang S,et al.G-protein beta 3 subunit 825 CC genotype is associated with unexplained(functional)dyspepsia[J].Gastroenterology,2004,126(4):971-979. 被引量:1
  • 9Cremonini F,Camilleri M,McKinzie S,et al.Effect of CCK-1 antagonist,dexioxiglumide,in female patients with irritable bowel syndrome:a pharmacodynamie and pharmacogenomic study[J].Am J Gastroenterol,2005,100(3):652-663. 被引量:1
  • 10Dressman D A,Camilleri M,Mayer E A.AGA technical review on irritable syndrome[J].Gastroenterology,2002,123(6):2108-2131. 被引量:1

共引文献32

同被引文献106

引证文献12

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部